APP and Alzheimer disease: The APP knock-in mice and earlier transgenic mouse models of AD that express familial AD mutations in APP all develop not only amyloid, neuritic, astrocytic, and microglial pathologies, but also cognitive abnormalities and even biomarker evidence of neurodegeneration [38,39].